To recover p53’s decreased function that leads to drug resistance, interventions with nanomedicine to deliver small molecules or MDM2 inhibitors, plus the specific treatment against the tumor, could help advance the battle against cancer drug resistance. This evidence concerns the gene TP53 and cancer.